PCN41 ECONOMIC EVALUATION OF TRASTUZUMAB FOR THE ADJUVANT TREATMENT OF HER2 POSITIVE EARLY BREAST CANCER IN THE NETHERLANDS

Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66577-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66577-1/fulltext
Section Title :
Section Order : 412
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66577-1&doi=10.1016/S1098-3015(10)66577-1
HEOR Topics :
Tags :
Regions :